Page last updated: 2024-08-18

pyrroles and Acute Disease

pyrroles has been researched along with Acute Disease in 129 studies

Research

Studies (129)

Timeframe	Studies, this research(%)	All Research%
pre-1990	22 (17.05)	18.7374
1990's	5 (3.88)	18.2507
2000's	73 (56.59)	29.6817
2010's	26 (20.16)	24.3611
2020's	3 (2.33)	2.80

Authors

Authors	Studies
Arbushites, MC; Barkey, N; Howell, MD; Liu, H; Owens, S; Paczesny, S; Pratta, M; Schroeder, MA; Socie, G	1
Ailani, J; Dodick, DW; Halker Singh, RB; Lipton, RB; Shewale, AR; Trugman, JM; Viswanathan, HN; Yu, SY; Zhao, S	1
Boyko, M; Frank, D; Grinshpun, J; Gruenbaum, BF; Knyazer, B; Kuts, R; Melamed, I; Savir, S; Vinokur, M; Zlotnik, A	1
Breault, DT; Carlone, DL; Deary, L; Ediger, T; Richmond, CA; Rickner, H; Shah, MS; Tovaglieri, A; Zhou, F	1
Anderson, D; Finberg, RW; Fleischhackl, R; Kauffman, RS; Kosoglou, T; Lanno, R; Leopold, L; van Duijnhoven, W; Vingerhoets, J	1
Budde, K; Campistol, JM; Eris, J; Gopalakrishnan, U; Hartmann, A; Kho, MM; Klupp, J; Krishnan, I; Rostaing, L; Russ, G; Tedesco-Silva, H; Vitko, S	1
Chakrabarti, A; Dhamija, P; Hota, D; Kochhar, R; Sachdev, A	1
Chen, Y; Liang, F; Shi, P; Wang, Q; Wei, D; Xiao, X; Yao, L; Yin, X; Zhang, X	1
Ando, Y; Funahashi, Y; Gotoh, M; Inada-Inoue, M; Matsukawa, Y; Sassa, N	1
Aerts, S; Cools, J; Cox, L; de Bock, CE; Degryse, S; Demeyer, S; Fiers, M; Geerdens, E; Gianfelici, V; Gielen, O; Hulselmans, G; Jacobs, K; Meijerink, JP; Mentens, N; Tousseyn, T	1
Császár, A	1
Ellis, S; Marsh, JE; Sampson, S; Savage, P; Winn, SK	1
El-Remessy, AB; Elewa, HF; Ergul, A; Fagan, SC; Frye, RF; Johnson, MH; Kozak, A	1
Akyurek, N; Benekli, M; Buyukberber, S; Coskun, U; Demirci, U; Karakan, T; Tonyali, O; Yildiz, R	1
Faergeman, O; Fayyad, R; Holdaas, H; Holme, I; Kastelein, JJ; Larsen, ML; Lindahl, C; Olsson, AG; Pedersen, TR; Tikkanen, MJ	1
Cui, L; Du, W; Li, M; Liu, L; Wang, L; Yang, R; Zhang, X	1
Chou, SY; Gulmi, FA; Kamdar, C; Kim, H; Mooppan, UM	1
Corinaldesi, R; Morselli-Labate, AM; Pezzilli, R	1
Abdel-Aziz, NA; Abo-Elmatty, DM; Ghattas, MH; Tawfik, MK	1
Singh, M; Slawsky, MT; Valania, G	1
Byrne, CD; Chipperfield, AJ; Clough, GF; Gamble, J; Krentz, AJ; L'Esperance, V; Turzyniecka, M; Walter, L	1
Aktunc, E; Arasli, M; Barut, F; Gun, BD; Kayhan, B	1
Brielmaier, J; McDonald, CG; Smith, RF	1
Fang, YH; Huh, KH; Joo, DJ; Kim, MS; Kim, YS; Lim, BJ; Suh, H	1
Bonneau, O; Ciuclan, L; Duggan, N; Good, R; Holmes, AM; Hussey, M; Jarai, G; Jones, P; Morrell, NW; Stringer, R; Thomas, M; Walker, C; Westwick, J	1
Czaikoski, PG; Dias-Junior, CA; Neto-Neves, EM; Pereira, RP; Spiller, F; Tanus-Santos, JE; Uzuelli, JA	1
Blonder, JP; Colagiovanni, DB; Green, LS; Mutka, SC; Qiu, J; Richards, JP; Rosenthal, GJ; Stout, AM; Strong, SA; Sun, X; Wasley, JW	1
Asai, K; Hata, N; Kobayashi, N; Matsushita, M; Mizuno, K; Shinada, T; Shirakabe, A; Tomita, K; Tsurumi, M; Yokoyama, S	1
Barraza, SJ; Blakely, PK; Bolduc, KL; Irani, DN; Keep, RF; Larsen, SD; Miller, DJ; Sindac, JA; Yestrepsky, BD	1
Fenech, ME; Mackay, JW; Myint, KS	1
Vogelzang, NJ	1
Arnaboldi, L; Baetta, R; Bellosta, S; Bonomo, A; Corsini, A; Ferri, N; Granata, A; Miglietta, D; Oliva, F; Ongini, E	1
Giles, FJ	1
Lewin, JJ; Nappi, JM; Taylor, MH	1
Chaitman, BR; Ezekowitz, M; Ganz, P; Leslie, SJ; Oliver, MF; Olsson, AG; Schwartz, GG; Stern, T; Waters, DD; Zeiher, A	1
Abrams, TJ; Cherrington, JM; Heinrich, MC; Hong, W; Lee, LB; Louie, SG; Manning, WC; Murray, LJ; Ngai, TJ; O'Farrell, AM; Smolich, BD; Town, A; Wong, LM; Yee, KW; Yuen, HA	1
Anthopoulou, A; Elisaf, M; Miltiadous, G	1
Nissen, SE	1
Albitar, M; Cherrington, JM; Cooper, MA; Cortes, JE; Giles, FJ; Hannah, AL; Hong, W; Kantarjian, HM; Karp, JE; Lancet, JE; Louie, SG; O'Brien, SM; O'Farrell, AM; Silverman, LR; Stopeck, AT; Verstovsek, S; Yuen, HA	1
Böhm, M; Fries, R	1
Bossaller, C; Gitt, AK; Heer, T; Juenger, C; Limbourg, P; Meisenzahl, C; Schiele, R; Senges, J; Wienbergen, H	1
Averkov, OV; Deev, AD; Gratsianskiĭ, NA; Pokrovskaia, EV; Vaulin, NA	1
Averkov, OV; Deev, AD; Gratsianskiĭ, NA; Pokrovskaia, EV; Slavina, NN; Vaulin, NA	1
Ganz, P; Kinlay, S; Leslie, SJ; Libby, P; Olsson, AG; Rifai, N; Sasiela, WJ; Schwartz, GG; Szarek, M	1
Arikian, S; Ganz, P; Schwartz, GG; Waters, D	1
Isomustajärvi, M; Laakso, J; Laaksonen, R; Lakka, TA; Lehtimäki, T; Päivä, H; Ruokonen, I; Salonen, JT; Valkonen, VP	1
Hiraoka, M; Ito, S; Mayumi, M; Noiri, E; Ohta, N; Sato, S; Shibata, R; Tsukahara, H	1
Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Rodis, FI; Tselepis, AD	1
Li, J; Xu, Z; Ye, H; Zhao, S; Zhou, H	1
Fukao, K; Kobayashi, S; Nagai, M; Seino, K; Shikata, K; Taniguchi, M; Yamauchi, T	1
Hager, P; Hagman, B; Strömmer, L; Wikström, AC	1
Daida, H; Miyauchi, K; Shimada, K	1
Albitar, M; Cherrington, JM; Giles, FJ; Hannah, AL; Hong, W; Karp, JE; Lancet, JE; Louie, SG; O'Farrell, AM; Silverman, LR; Smolich, B; Stopeck, AT; Yuen, HA	1
Daida, H; Kurata, T; Miyauchi, K; Okazaki, S; Sato, H; Shimada, K; Yokoyama, T	1
Lange, AP; Szucs, TD	1
McGowan, MP	1
Cannon, CP; Ray, KK	1
Dolan, JG; Nautiyal, A; Singh, S	1
Advani, AS	1
Casciano, R; Gómez-Gerique, JA; Rejas, J; Stern, L	1
Schwartz, GG	1
Badaracco, R; Brizuela, M; Cialzeta, JR; Doval, H; Farías, EF; Franciosi, V; Macin, SM; Medina, F; Perna, ER; Tajer, C	1
de Graaf, J; Stalenhoef, AF; van Tits, LJ	1
Boyacioglu, S; Gur, G; Kanbay, M; Sekuk, H; Yilmaz, U	1
Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Tselepis, AD	1
Gheorghiade, M; Orlandi, C; Zimmer, CA	1
Olsson, AG; Sasiela, WJ; Schwartz, GG; Szarek, M	1
Braunwald, E; Cairns, R; Cannon, CP; Jackson, G; McCabe, CH; Ray, KK; Sacks, FM; Tonkin, AM	1
Braunwald, E; Cannon, CP; Morrow, DA; Pfeffer, MA; Ray, KK; Wiviott, SD	1
Braunwald, E; Cairns, R; Cannon, CP; Gibson, CM; Kirtane, AJ; McCabe, CH; Morrow, DA; Ray, KK; Ridker, PM; Rifai, N; Skene, AM	1
Amyot, R; Arnold, M; Bonafede, N; Cannon, CP; Dupuis, J; Lonn, E; Ricci, J; Rouleau, JL; Roux, R; Tardif, JC; Title, LM; Woo, A	1
Baz, A; Clofent, J; de Castro, ML; de Luaces, C; Hermo, JA; Pérez, R	1
Qi, SS; Shen, XQ; Zeng, GF; Zhou, HN; Zhou, SH; Zhou, T	1
Braunwald, E; Cannon, CP; McCabe, CH; Morrow, DA; Murphy, SA; O'Donoghue, M; Sabatine, MS	1
Böhmer, FD; Cénac, C; Dove, S; Eichhorn, E; Elz, S; Fischer, T; Heidel, F; Höcher, H; Hufsky, H; Mahboobi, S; Pongratz, H; Sellmer, A; Sicker, M; Stocking, C; Trümpler, A; Uecker, A	1
Braunwald, E; Cannon, CP; Jarolim, P; McCabe, CH; Morrow, DA; Ray, KK; Sabatine, MS; Scirica, BM; Shui, A	1
Alberti, A; Bergamasco, L; Brscic, E; Celeste, A; De Bernardi, A; Formato, L; Fuster, V; Moretti, C; Pucci, A; Sheiban, I; Trevi, G	1
Bainbridge, T; Braziel, RM; Cherrington, JM; Griffith, DJ; Haley, AD; Heinrich, MC; McGreevey, L; O'Farrell, AM; Schittenhelm, MM; Town, A; Tyner, JW; Yee, KW	1
Hiramatsu, A; Imai, N; Imamura, A; Itoh, M; Mihara, H; Miwa, H; Nitta, M; Satoh, A; Shikami, M; Suganuma, K; Watarai, M	1
Alves-Filho, JC; Cunha, FQ; Figueiredo-Lopes, L; Gerlach, RF; Semprini, MC; Souza-Costa, DC; Tanus-Santos, JE	1
Alhan, CC; Avkaroğullari, M; Cayli, M; Demir, M; Demirtaş, M; Dönmez, Y; Inal, T; Kanadaşi, M; Koç, M; San, M; Usal, A	1
Colonna, G; Di Sciascio, G; Fischetti, D; Miglionico, M; Montinaro, A; Pasceri, V; Patti, G; Sardella, G	1
de Lima Lopes, G; Rocha Lima, CM	1
Anderson, DR; Caspers, N; Kurumbail, RG; Mahoney, MW; Meyers, MJ; Mourey, RJ; Poda, GI; Reitz, DB; Schindler, JF; Vernier, WF	1
Earm, YE; Han, J; Jung, ID; Kang, SH; Kim, N; Ko, JH; Park, WS; Park, YM; Son, YK; Warda, M	1
Blaser, BW; Briesewitz, R; Caligiuri, MA; Duchemin, AM; Kusewitt, DF; Liu, T; Wang, J; Wang, L	1
Braunwald, E; Cannon, CP; Morrow, DA; Ray, KK; Rifai, N; Sabatine, MS; Shui, A	1
Bandy, DP; Daniels, SE; Desjardins, PJ; Lawson, JE; Link, AJ; Moberly, JB; Truitt, KE; Xu, J	1
Blanco, M; Castellanos, M; Castillo, J; Dávalos, A; García-Gil, M; Leira, R; Lizasoain, I; Moro, MA; Nombela, F; Rodriguez-Yáñez, M; Serena, J; Vivancos, J	1
Abdellah, AT; Clark, AL; Cleland, JG; Coletta, AP; Khaleva, O	1
Ebdrup, L; Granfeldt, A; Hokland, M; Krog, J; Larsen, PØ; Tønnesen, E; Vestergaard, C	1
Calvo, E; Prat, A; Serrano, C; Valverde, C	1
Ahmad, S	1
Tishler, PV; Winston, SH	1
Forrest, WH	1
Graham, DJ; Moore, MR	1
Gaismayer, K; Petera, P; Tausch, G	1
Nassif, RI; Stefanini, M	1
Capaldo, R; DiGregorio, JG; Everts, EA; Katz, SM	1
Gorchein, A	1
Englert, H; Klaus, E; Zwergel, T; Zwergel, U	1
Donati, G; Spinazzè, R	1
Balderrama, DS; Eichinger, MR; Herrera, GM; Resta, JM; Resta, TC; Richardson, LA; Walker, BR	1
Alicicco, E; Delfino, M; Kleszczynski, D	1
Morice, AH; Woodmansey, PA; Zhang, F	1
Blauw, GJ; de Man, FH; Jukema, JW; Smelt, AH; van der Laarse, A; Weverling-Rijnsburger, AW	1
Belaïche, G; Ley, G; Slama, JL	1
El Menjawi, I; Fladerer, P; Krause, R; Pohanka, E; Wenisch, C	1
Berdel, WE; Bieker, R; Büchner, T; Fiedler, W; Göner, M; Kelsey, S; Kreuter, M; Mesters, RM; Padró, T; Scigalla, P; Steins, M	1
Dimitroulakos, J; Minden, MD; Penn, LZ; Tan, MM; Wong, WW; Xia, Z	1
Mikhaildis, DP; Reynolds, TR; Wierzbicki, AS	1
Chaitman, BR; Ezekowitz, MD; Ganz, P; Oliver, MF; Olsson, AG; Schwartz, GG; Waters, D; Zeiher, A	1
Biasi, G; Marcolongo, R	1
Barsotti, A; Brunelli, C; Ghigliotti, G; Leslie, S; Olivotti, L; Rossettin, P; Spallarossa, P	1
Mandó, OG; Ridruejo, E	1
Brodie, MJ; Goldberg, A; Graham, DJ; McColl, KE; Moore, MR	1
Formgren, B; Wetterberg, L	1
Gordon, GD; Pascoe, MD; Temple-Camp, CR	1
Irvine, DG; Wetterberg, L	1
Berk, PD; Schalch, D; Tschudy, DP; Waxman, AD	1
Eales, L; Sears, WG	1
Stein, JA; Tschudy, DP	1
Doss, M; Marver, HS; Meyer, UA; Rees, AC; Strand, LJ	1
Berlin, NI; Bloomer, JR; Jones, EA	1
Bannerman, RM; Kreimer-Birnbaum, M; Mosovich, LL	1
Carr, AA; Sanders, JL	1
Samuels, S; Veliz, G	1
Neuberger, A	1
Goldberg, A	1

Reviews

11 review(s) available for pyrroles and Acute Disease

Article	Year
Tofacitinib for acute rheumatoid arthritis patients who have had an inadequate response to disease-modifying antirheumatic drug (DMARD): a systematic review and meta-analysis. Clinical rheumatology, 2014, Volume: 33, Issue:2 Topics: Acute Disease; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome	2014
[Important aim of statin therapy: ischemic cardiovascular event (stroke)]. Ideggyogyaszati szemle, 2008, Jul-30, Volume: 61, Issue:7-8 Topics: Acute Disease; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Meta-Analysis as Topic; Myocardial Ischemia; Pyrroles; Recurrence; Stroke	2008
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists? Current heart failure reports, 2011, Volume: 8, Issue:3 Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins	2011
New drugs in acute myeloid leukemia. Current oncology reports, 2002, Volume: 4, Issue:5 Topics: Acute Disease; Adenine Nucleotides; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Bevacizumab; Boronic Acids; Bortezomib; Clofarabine; Cytosine; Decitabine; Dioxolanes; Humans; Indoles; Leukemia, Myeloid; Phthalazines; Pyrazines; Pyridines; Pyrroles; Thionucleotides	2002
Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective. Journal of the American College of Cardiology, 2003, Feb-19, Volume: 41, Issue:4 Suppl S Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Atorvastatin; Coronary Angiography; Coronary Artery Disease; Disease Progression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Outcome Assessment, Health Care; Pyrroles; Randomized Controlled Trials as Topic	2003
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure]. Medizinische Klinik (Munich, Germany : 1983), 2003, Jun-15, Volume: 98, Issue:6 Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine	2003
Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology. Current opinion in lipidology, 2004, Volume: 15, Issue:6 Topics: Acute Disease; Animals; Atorvastatin; Cholesterol; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Endothelial Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome; T-Lymphocytes	2004
C-kit as a target in the treatment of acute myelogenous leukemia. Current hematology reports, 2005, Volume: 4, Issue:1 Topics: Acute Disease; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Clinical Trials as Topic; Hematopoiesis; Humans; Imatinib Mesylate; Indoles; Leukemia, Myeloid; Mice; Oxindoles; Piperazines; Propionates; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Stem Cell Factor	2005
Role of vasopressin antagonists in the management of acute decompensated heart failure. Current heart failure reports, 2005, Volume: 2, Issue:3 Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Stroke Volume; Tolvaptan; Treatment Outcome; Vasoconstriction; Vasopressins	2005
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. Journal of the American College of Cardiology, 2006, Jun-06, Volume: 47, Issue:11 Topics: Acute Disease; Atorvastatin; Cardiac Output, Low; Coronary Disease; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome	2006
Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine, 1970, Volume: 49, Issue:1 Topics: Acute Disease; Adolescent; Adult; Blood Volume Determination; Cholesterol; Electroencephalography; Female; Follow-Up Studies; Glucose; Humans; Levulinic Acids; Liver; Liver Function Tests; Male; Middle Aged; Neurologic Examination; Porphyrias; Propionates; Pyrroles; Thyroid Function Tests	1970

Trials

37 trial(s) available for pyrroles and Acute Disease

Article	Year
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease. British journal of haematology, 2022, Volume: 198, Issue:4 Topics: Acetonitriles; Acute Disease; Adrenal Cortex Hormones; Biomarkers; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Proteomics; Pyrazoles; Pyrimidines; Pyrroles	2022
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II. Headache, 2020, Volume: 60, Issue:4 Topics: Acute Disease; Adult; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Reported Outcome Measures; Patient Satisfaction; Pyridines; Pyrroles	2020
Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial. The Journal of infectious diseases, 2019, 03-15, Volume: 219, Issue:7 Topics: Acute Disease; Adult; Antiviral Agents; Diarrhea; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Oseltamivir; Pyridines; Pyrimidines; Pyrroles; Time Factors; Viral Load; Viral Proteins; Virus Shedding	2019
Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:7 Topics: Acute Disease; Adult; Antineoplastic Agents; Biopsy; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Retrospective Studies; Sirolimus; Transplantation, Homologous; Treatment Outcome	2013
Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2014, Volume: 33, Issue:2 Topics: Acute Disease; Adult; Atorvastatin; Colitis, Ulcerative; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intention to Treat Analysis; Male; Middle Aged; Placebo Effect; Prednisolone; Pyrroles; Severity of Illness Index	2014
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial. Journal of internal medicine, 2010, Volume: 267, Issue:6 Topics: Acute Disease; Aged; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cardiovascular Diseases; Female; Glomerular Filtration Rate; Heart Arrest; Heptanoic Acids; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Pyrroles; Regression Analysis; Simvastatin	2010
Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment. Microcirculation (New York, N.Y. : 1994), 2011, Volume: 18, Issue:1 Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Flow Velocity; Female; Heptanoic Acids; Humans; Hyperemia; Hyperinsulinism; Insulin Resistance; Male; Microcirculation; Middle Aged; Obesity, Abdominal; Pyrroles; Risk Factors; Vasodilation	2011
Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failure. Journal of cardiology, 2012, Volume: 59, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Atorvastatin; Female; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Matrix Metalloproteinase 2; Prognosis; Pyrroles; Survival Rate; Time Factors; Treatment Outcome	2012
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation, 2002, Sep-24, Volume: 106, Issue:13 Topics: Acute Disease; Aged; Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cholesterol; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Incidence; Lipids; Male; Myocardial Infarction; Myocardial Ischemia; Proportional Hazards Models; Pyrroles; Risk; Risk Assessment; Secondary Prevention; Stroke; Treatment Outcome	2002
SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes. Blood, 2003, Aug-01, Volume: 102, Issue:3 Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Bone Marrow Examination; Humans; Indoles; Leukemia, Myeloid; Middle Aged; Myelodysplastic Syndromes; Necrosis; Pharmacokinetics; Protein-Tyrosine Kinases; Pyrroles; Remission Induction; Salvage Therapy	2003
[Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin]. Kardiologiia, 2003, Volume: 43, Issue:1 Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Coronary Disease; Drug Administration Schedule; Electrocardiography; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Inflammation; Male; Middle Aged; Platelet Aggregation; Pravastatin; Pyrroles; Time Factors	2003
[Non ST elevation acute coronary syndrome: early use of pravastatin or atorvastatin is associated with divergent changes of parameters of hemostasis]. Kardiologiia, 2003, Volume: 43, Issue:6 Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Electrocardiography; Female; Heptanoic Acids; Homeostasis; Humans; Male; Middle Aged; Pravastatin; Pyrroles; Syndrome; Time Factors	2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation, 2003, Sep-30, Volume: 108, Issue:13 Topics: Acute Disease; Aged; Angina, Unstable; Apolipoproteins; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Pyrroles; Serum Amyloid A Protein; Syndrome; Troponin	2003
Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels? Atherosclerosis. Supplements, 2003, Volume: 4, Issue:4 Topics: Acute Disease; Adult; Aged; Arginine; Atorvastatin; Biomarkers; Blood Glucose; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Finland; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Prospective Studies; Pyrroles; Risk Factors; Simvastatin; Statistics as Topic; Triglycerides	2003
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes. Circulation, 2004, Mar-23, Volume: 109, Issue:11 Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; CD40 Ligand; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inactivation, Metabolic; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Stents; Ticlopidine; Treatment Outcome	2004
Atorvastatin lowers plasma matrix metalloproteinase-9 in patients with acute coronary syndrome. Clinical chemistry, 2004, Volume: 50, Issue:4 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Pyrroles	2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia. Leukemia research, 2004, Volume: 28, Issue:7 Topics: Acute Disease; Adult; Aged; Bone Marrow; Down-Regulation; Female; fms-Like Tyrosine Kinase 3; Humans; Indoles; Leukemia, Myeloid; Male; Membrane Proteins; Middle Aged; Mutation; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyrroles; Receptor Protein-Tyrosine Kinases; Stem Cell Factor	2004
Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation, 2004, Aug-31, Volume: 110, Issue:9 Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atorvastatin; Cardiovascular Agents; Cholesterol, LDL; Cilostazol; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Heparin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Tetrazoles; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional	2004
There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation, 2004, Oct-19, Volume: 110, Issue:16 Topics: Acute Disease; Atorvastatin; Coronary Disease; Disease-Free Survival; Double-Blind Method; Heart Arrest; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Life Tables; Myocardial Infarction; Myocardial Ischemia; Pyrroles; Stroke; Substance Withdrawal Syndrome; Syndrome; Withholding Treatment	2004
Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study. American heart journal, 2005, Volume: 149, Issue:3 Topics: Acute Disease; Acute-Phase Proteins; Anti-Inflammatory Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Double-Blind Method; Drug Administration Schedule; Female; Guidelines as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Secondary Prevention; Syndrome	2005
Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial. Diabetes care, 2005, Volume: 28, Issue:10 Topics: Acute Disease; Aged; Atorvastatin; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Metabolic Syndrome; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Pyrroles; Recurrence; Risk Factors; Treatment Outcome	2005
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome; Time Factors	2005
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cross-Sectional Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pravastatin; Pyrroles; Risk Factors; Syndrome	2005
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial). The American journal of cardiology, 2005, Nov-01, Volume: 96, Issue:9 Topics: Acute Disease; Anticholesteremic Agents; Atorvastatin; Blood Flow Velocity; Brachial Artery; Cholesterol, LDL; Coronary Disease; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pravastatin; Prognosis; Pyrroles; Syndrome; Ultrasonography; Vasodilation	2005
The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome. Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 368, Issue:1-2 Topics: Acute Disease; Atorvastatin; C-Reactive Protein; Coronary Disease; Female; Heptanoic Acids; Humans; Lipid Metabolism; Middle Aged; Peroxidase; Pyrroles; Syndrome	2006
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) Circulation, 2006, Apr-11, Volume: 113, Issue:14 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acute Disease; Atorvastatin; Coronary Disease; Double-Blind Method; Enzymes; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Phospholipases A; Phospholipases A2; Pravastatin; Pyrroles; Survival Analysis; Syndrome; Thrombolytic Therapy; Treatment Outcome	2006
In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment. Atherosclerosis, 2007, Volume: 194, Issue:1 Topics: Acute Disease; Aged; Angina, Unstable; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherectomy, Coronary; Atorvastatin; Coronary Artery Disease; Coronary Vessels; Female; Glycophorins; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunohistochemistry; Male; Middle Aged; Pravastatin; Pyrroles	2007
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. Journal of the American College of Cardiology, 2007, Mar-27, Volume: 49, Issue:12 Topics: Acute Disease; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Atorvastatin; Coronary Disease; Double-Blind Method; Female; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pyrroles; Syndrome; Time Factors; Treatment Outcome	2007
Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation, 2007, Jun-19, Volume: 115, Issue:24 Topics: Acute Disease; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Biomarkers; Coronary Artery Disease; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Monocytes; Neopterin; Pravastatin; Prognosis; Pyrroles; Risk Factors; Secondary Prevention; Survival Analysis	2007
A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain. Clinical therapeutics, 2007, Volume: 29, Issue:3 Topics: Acute Disease; Adolescent; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Molar, Third; Pain Measurement; Pain, Postoperative; Pyrazoles; Pyrroles; Sulfonamides; Tooth Extraction; Tooth, Impacted; Treatment Outcome	2007
Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology, 2007, Aug-28, Volume: 69, Issue:9 Topics: Acute Disease; Aged; Atorvastatin; Brain Ischemia; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neuroprotective Agents; Odds Ratio; Pyrroles; Risk Factors; Stroke; Survival Analysis; Time Factors; Treatment Outcome; Withholding Treatment	2007
Orally administered zomepirac and parenterally administered morphine. Comparison for the treatment of postoperative pain. JAMA, 1980, Nov-21, Volume: 244, Issue:20 Topics: Acute Disease; Administration, Oral; Adult; Cyclooxygenase Inhibitors; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Morphine; Pain, Postoperative; Pyrroles; Tolmetin	1980
[A clinical study to determine the optimal dosage of ST-679 in the treatment of rheumatic diseases]. La Clinica terapeutica, 1993, Volume: 142, Issue:1 Pt 2 Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Dose-Response Relationship, Drug; Drug Tolerance; Female; Glycine; Humans; Male; Middle Aged; Pyrroles; Rheumatic Diseases	1993
[Clinical trial comparing a new NSAID with 2 different dosages and diclofenac in patients with arthralgia in acute phase]. La Clinica terapeutica, 1995, Volume: 146, Issue:10 Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Drug Administration Schedule; Glycine; Humans; Male; Pyrroles	1995
Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:3 Topics: Acetylcholine; Acute Disease; Anticholesteremic Agents; Atorvastatin; Blood Pressure; Chronic Disease; Endothelium, Vascular; Free Radical Scavengers; Heptanoic Acids; Humans; Hypertriglyceridemia; Injections, Intravenous; Male; Middle Aged; Nitroprusside; Pyrroles; Serotonin; Triglycerides; Vasodilation; Vasodilator Agents	2000
[Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis]. Minerva medica, 2001, Volume: 92, Issue:5 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Female; Follow-Up Studies; Glycine; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Osteoarthritis; Pyrroles; Time Factors	2001
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:4 Topics: Acute Disease; Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Platelet Aggregation; Pyrroles; Thromboplastin; Thrombosis	2002

Other Studies

81 other study(ies) available for pyrroles and Acute Disease

Article	Year
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube. Journal of visualized experiments : JoVE, 2020, 04-28, Issue:158 Topics: Acute Disease; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Intubation, Gastrointestinal; Liver; Male; Pyrroles; Rats	2020
JAK/STAT-1 Signaling Is Required for Reserve Intestinal Stem Cell Activation during Intestinal Regeneration Following Acute Inflammation. Stem cell reports, 2018, 01-09, Volume: 10, Issue:1 Topics: Acute Disease; Animals; Apoptosis; Cytokines; Enteritis; Inflammation; Intestinal Mucosa; Intestine, Small; Janus Kinases; Mice; Mice, Transgenic; Piperidines; Pyrimidines; Pyrroles; Regeneration; Signal Transduction; STAT1 Transcription Factor; Stem Cells	2018
Acute aortic dissection in a patient receiving multiple tyrosine kinase inhibitors for 5 years. Aktuelle Urologie, 2014, Volume: 45, Issue:2 Topics: Acute Disease; Angiogenesis Inhibitors; Aortic Aneurysm; Aortic Dissection; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Fatal Outcome; Humans; Indoles; Kidney Neoplasms; Long-Term Care; Lymphatic Metastasis; Male; Middle Aged; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Tomography, X-Ray Computed	2014
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model. Blood, 2014, Nov-13, Volume: 124, Issue:20 Topics: Acute Disease; Animals; Cell Transformation, Neoplastic; Disease Models, Animal; Enzyme Activation; Janus Kinase 1; Janus Kinase 3; Leukemia, T-Cell; Male; Mice; Mice, Inbred BALB C; Mutation; Piperidines; Pyrimidines; Pyrroles; Signal Transduction; T-Lymphocytes	2014
Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:2 Topics: Acute Disease; Acute Kidney Injury; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Nephritis, Interstitial; Protein Kinase Inhibitors; Pyrroles; Sunitinib	2009
Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 330, Issue:2 Topics: Acute Disease; Animals; Atorvastatin; Brain Ischemia; Cerebral Hemorrhage; Diabetes Mellitus, Type 2; Drug Administration Schedule; Heptanoic Acids; Male; Pyrroles; Rats; Rats, Wistar; Time Factors	2009
Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Acute Disease; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Liver; Liver Failure; Middle Aged; Peritoneal Neoplasms; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sunitinib	2010
Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain research, 2010, Apr-14, Volume: 1325 Topics: Acute Disease; Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Atorvastatin; Blood-Brain Barrier; Brain; Brain Edema; Brain Ischemia; Capillary Permeability; Down-Regulation; Heptanoic Acids; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Phospholipases A2, Cytosolic; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Stroke; Time Factors	2010
Atorvastatin protects renal function in the rat with acute unilateral ureteral obstruction. Urology, 2010, Volume: 75, Issue:4 Topics: Acute Disease; Albuminuria; Animals; Atorvastatin; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Ureteral Obstruction	2010
Tyrosine kinase inhibitors and acute pancreatitis. JOP : Journal of the pancreas, 2010, May-05, Volume: 11, Issue:3 Topics: Acute Disease; Antineoplastic Agents; Humans; Indoles; Neoplasms; Pancreatitis; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sunitinib	2010
Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction. European review for medical and pharmacological sciences, 2010, Volume: 14, Issue:6 Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Atorvastatin; C-Reactive Protein; Electrocardiography; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-10; Male; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Pyrroles; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha	2010
The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis. Immunopharmacology and immunotoxicology, 2011, Volume: 33, Issue:4 Topics: Acute Disease; Animals; Atorvastatin; Colitis; Cytokines; Disease Models, Animal; Down-Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mice; Mice, Inbred BALB C; Pyrroles; Th1 Cells; Th2 Cells	2011
Effects of acute stress on acquisition of nicotine conditioned place preference in adolescent rats: a role for corticotropin-releasing factor 1 receptors. Psychopharmacology, 2012, Volume: 219, Issue:1 Topics: Acute Disease; Age Factors; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Male; Nicotine; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stress, Psychological	2012
The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival. The Journal of surgical research, 2011, Volume: 171, Issue:1 Topics: Acute Disease; Animals; Disease Models, Animal; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Kidney; Liver; Male; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Rats; Rats, Inbred BN; Rats, Inbred Lew; Tacrolimus; Transplantation, Heterotopic; Transplantation, Homologous	2011
A novel murine model of severe pulmonary arterial hypertension. American journal of respiratory and critical care medicine, 2011, Nov-15, Volume: 184, Issue:10 Topics: Acute Disease; Animals; Blotting, Western; Cytokines; Disease Models, Animal; Echocardiography; Female; Fluorescent Antibody Technique; Gene Expression Profiling; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Pyrroles; Receptors, Vascular Endothelial Growth Factor	2011
Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. European journal of pharmacology, 2011, Nov-30, Volume: 670, Issue:2-3 Topics: Acute Disease; Animals; Atorvastatin; Bronchoalveolar Lavage; Drug Synergism; Enzyme Activation; Heart Ventricles; Hemodynamics; Heptanoic Acids; Lipid Peroxidation; Lung; Male; Matrix Metalloproteinases; Myocytes, Cardiac; Neutrophils; Oxidative Stress; Piperazines; Pulmonary Embolism; Purines; Pyrroles; Sildenafil Citrate; Sulfones	2011
Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification. Bioorganic & medicinal chemistry letters, 2012, Mar-15, Volume: 22, Issue:6 Topics: Acute Disease; Aldehyde Oxidoreductases; Animals; Anti-Asthmatic Agents; Asthma; Benzamides; Enzyme Inhibitors; Humans; Male; Mice; Ovalbumin; Pyrroles; S-Nitrosoglutathione; S-Nitrosothiols; Structure-Activity Relationship	2012
Novel inhibitors of neurotropic alphavirus replication that improve host survival in a mouse model of acute viral encephalitis. Journal of medicinal chemistry, 2012, Apr-12, Volume: 55, Issue:7 Topics: Acute Disease; Alphavirus; Alphavirus Infections; Animals; Antiviral Agents; Brain; Cell Survival; Encephalitis, Viral; Indoles; Membranes, Artificial; Mice; Microsomes, Liver; Neurons; Permeability; Piperidines; Pyrroles; Replicon; Spinal Cord; Stereoisomerism; Structure-Activity Relationship; Thiophenes; Viral Tropism; Virus Replication	2012
Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin. British journal of hospital medicine (London, England : 2005), 2012, Volume: 73, Issue:2 Topics: Acute Disease; Aged; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Rhabdomyolysis; Warfarin	2012
Antiangiogenic agents, chemotherapy, and the treatment of metastatic transitional cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-20, Volume: 31, Issue:6 Topics: Acute Disease; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Indoles; Male; Neoplasm Metastasis; Neutropenia; Pancreatitis; Pyrroles; Sunitinib; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms	2013
Nitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:3 Topics: Acute Disease; Animals; Atherosclerosis; Atorvastatin; Carotid Arteries; Cell Survival; Chemotaxis, Leukocyte; Cholesterol; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-8; Male; Molecular Structure; Monocytes; Neutrophil Infiltration; Neutrophils; Nitric Oxide Donors; Pyrroles; Rabbits	2013
Rhabdomyolysis with concurrent atorvastatin and diltiazem. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:10 Topics: Acute Disease; Acute Kidney Injury; Atorvastatin; Cardiovascular Agents; Chemical and Drug Induced Liver Injury; Diltiazem; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis	2002
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. Blood, 2003, May-01, Volume: 101, Issue:9 Topics: Acute Disease; Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; Bone Marrow Transplantation; Endothelial Growth Factors; Enzyme Inhibitors; Female; fms-Like Tyrosine Kinase 3; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Leukemia, Myeloid; Lymphokines; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasm Proteins; Phosphorylation; Point Mutation; Protein Processing, Post-Translational; Protein Structure, Tertiary; Proto-Oncogene Proteins; Pyrroles; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Signal Transduction; Sunitinib; Tandem Repeat Sequences; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays	2003
Acute pancreatitis possibly associated with combined salicylate and atorvastatin therapy. JOP : Journal of the pancreas, 2003, Volume: 4, Issue:1 Topics: Acute Disease; Anticholesteremic Agents; Atorvastatin; Drug Combinations; Heptanoic Acids; Humans; Male; Middle Aged; Pancreatitis; Pyrroles; Salicylates; Treatment Outcome	2003
Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. The American journal of cardiology, 2003, Aug-01, Volume: 92, Issue:3 Topics: Acute Disease; Aged; Atorvastatin; Clopidogrel; Comorbidity; Coronary Disease; Drug Interactions; Drug Utilization; Female; Germany; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrroles; Registries; Stroke; Survival Analysis; Syndrome; Ticlopidine; Treatment Outcome	2003
Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The American journal of cardiology, 2003, Nov-01, Volume: 92, Issue:9 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Cost-Benefit Analysis; Economics, Pharmaceutical; Health Care Costs; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Myocardial Ischemia; Pyrroles; Secondary Prevention; Syndrome	2003
High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. Metabolism: clinical and experimental, 2003, Volume: 52, Issue:12 Topics: 8-Hydroxy-2'-Deoxyguanosine; Acute Disease; Arginine; Child; Child, Preschool; Creatinine; Deoxyguanosine; Dermatitis, Atopic; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Norleucine; Oxidative Stress; Pyrroles	2003
Prevention of acute and chronic allograft rejection by a novel retinoic acid receptor-alpha-selective agonist. International immunology, 2004, Volume: 16, Issue:5 Topics: Acute Disease; Animals; Arteriosclerosis Obliterans; Chronic Disease; Cyclin-Dependent Kinase Inhibitor Proteins; Cytokines; Furans; Graft Enhancement, Immunologic; Graft Rejection; Heart Transplantation; Lymphocyte Activation; Mice; Mice, Inbred Strains; Microtubule-Associated Proteins; Myocytes, Smooth Muscle; Pyrroles; Rats; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoids; Spleen; T-Lymphocytes, Cytotoxic	2004
CRF-receptor 1 blockade attenuates acute posttraumatic hyperglycemia in rats. The Journal of surgical research, 2004, Jun-01, Volume: 119, Issue:1 Topics: Acute Disease; Adrenocorticotropic Hormone; Animals; Biological Transport; Blood Glucose; Corticosterone; Dexamethasone; Glucocorticoids; Glucose; Hyperglycemia; Insulin; Male; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Wounds and Injuries	2004
Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench. Circulation, 2004, May-11, Volume: 109, Issue:18 Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Anion Exchange Resins; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Atorvastatin; CD4 Lymphocyte Count; Coronary Disease; Epichlorohydrin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Imidazoles; Immunophenotyping; Male; Prospective Studies; Pyrroles; Resins, Synthetic; Th1 Cells; Th2 Cells	2004
[Cost-effectiveness of atorvastatin in the early treatment of acute coronary syndromes in Germany based on the MIRACL study]. Medizinische Klinik (Munich, Germany : 1983), 2004, Sep-15, Volume: 99, Issue:9 Topics: Acute Disease; Adolescent; Adult; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Cost Savings; Cost-Benefit Analysis; Costs and Cost Analysis; Diagnosis-Related Groups; Double-Blind Method; Germany; Heptanoic Acids; Humans; Middle Aged; Myocardial Infarction; Patient Compliance; Placebos; Pyrroles; Randomized Controlled Trials as Topic; Retrospective Studies; Syndrome; Time Factors	2004
Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? JOP : Journal of the pancreas, 2004, Nov-10, Volume: 5, Issue:6 Topics: Acute Disease; Aged; Atorvastatin; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pancreatitis; Pyrimidines; Pyrroles; Recurrence; Rosuvastatin Calcium; Sulfonamides	2004
A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain. The European journal of health economics : HEPAC : health economics in prevention and care, 2004, Volume: 5, Issue:3 Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Coronary Artery Bypass; Cost Savings; Cost-Benefit Analysis; Diagnosis-Related Groups; Double-Blind Method; Economics, Pharmaceutical; Heptanoic Acids; Humans; Multicenter Studies as Topic; Myocardial Infarction; Placebos; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Spain; Syndrome; Time Factors; Treatment Outcome	2004
Statins in acute coronary syndromes: the sooner, the better? American heart journal, 2005, Volume: 149, Issue:3 Topics: Acute Disease; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Drug Administration Schedule; Guidelines as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Secondary Prevention; Syndrome	2005
Letter regarding article by Tsimikas et al, "high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial". Circulation, 2005, May-10, Volume: 111, Issue:18 Topics: Acute Disease; Antigen-Antibody Complex; Apolipoprotein B-100; Apolipoproteins B; Atorvastatin; Coronary Disease; Heptanoic Acids; Humans; Lipoproteins, LDL; Phospholipids; Pyrroles; Reagent Kits, Diagnostic; Reproducibility of Results	2005
Acute pancreatitis associated with combined lisinopril and atorvastatin therapy. Digestive diseases (Basel, Switzerland), 2005, Volume: 23, Issue:1 Topics: Acute Disease; Aged; Aged, 80 and over; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Drug Interactions; Heptanoic Acids; Humans; Lisinopril; Male; Pancreatitis; Pyrroles	2005
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes. Platelets, 2005, Volume: 16, Issue:5 Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Blood Platelets; CD40 Ligand; Cholesterol; Cholesterol, LDL; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Interactions; Female; Flow Cytometry; Heptanoic Acids; Humans; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Triglycerides	2005
Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome	2005
[Acute cholestatic hepatitis after atorvastatin reintroduction]. Gastroenterologia y hepatologia, 2006, Volume: 29, Issue:1 Topics: Acute Disease; Aged; Atorvastatin; Chemical and Drug Induced Liver Injury; Cholestasis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles	2006
Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase. Journal of medicinal chemistry, 2006, Jun-01, Volume: 49, Issue:11 Topics: Acute Disease; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Humans; In Vitro Techniques; Indoles; Leukemia, Myeloid; Ligands; Mice; Models, Molecular; Phosphorylation; Pyrroles; Receptors, Platelet-Derived Growth Factor; Structure-Activity Relationship	2006
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248). Leukemia, 2006, Volume: 20, Issue:11 Topics: Acute Disease; Amino Acid Sequence; Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Cell Division; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Humans; Indoles; Leukemia, Myeloid; Mice; Mice, Inbred BALB C; Mice, Nude; Mutagenesis, Site-Directed; Neoplasm Transplantation; Point Mutation; Pyrroles; Sunitinib	2006
t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt. British journal of haematology, 2006, Volume: 135, Issue:5 Topics: Acute Disease; Adult; Aged; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Female; Humans; Indoles; Leukemia, Myeloid; Male; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrroles; Translocation, Genetic; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2006
Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. Critical care medicine, 2007, Volume: 35, Issue:1 Topics: Acute Disease; Analysis of Variance; Animals; Atorvastatin; Disease Models, Animal; Drug Evaluation, Preclinical; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Injections, Intravenous; Luminescence; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microspheres; Nitrates; Nitrites; Proportional Hazards Models; Pulmonary Embolism; Pulmonary Wedge Pressure; Pyrroles; Random Allocation; Rats; Rats, Wistar; Survival Rate	2007
The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol. Heart and vessels, 2006, Volume: 21, Issue:5 Topics: Acute Disease; Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Follow-Up Studies; Heptanoic Acids; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Prognosis; Pyrroles; Serum Amyloid A Protein; Statistics as Topic; Syndrome; Treatment Outcome; Triglycerides	2006
Emphysematous cholecystitis in a patient with gastrointestinal stromal tumor treated with sunitinib. Pharmacotherapy, 2007, Volume: 27, Issue:5 Topics: Acute Disease; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antineoplastic Agents; Cholecystostomy; Emphysematous Cholecystitis; Gastrointestinal Stromal Tumors; Humans; Hyperbilirubinemia; Indoles; Leukocytosis; Male; Middle Aged; Neoplasm Metastasis; Probability; Pyrroles; Sunitinib; Tomography, X-Ray Computed	2007
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Journal of medicinal chemistry, 2007, May-31, Volume: 50, Issue:11 Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Crystallography, X-Ray; Humans; Inflammation; Intracellular Signaling Peptides and Proteins; Models, Molecular; Protein Serine-Threonine Kinases; Pyridines; Pyrroles; Rats; Structure-Activity Relationship; Tumor Necrosis Factor-alpha; U937 Cells	2007
Acute hypoxia induces vasodilation and increases coronary blood flow by activating inward rectifier K(+) channels. Pflugers Archiv : European journal of physiology, 2007, Volume: 454, Issue:6 Topics: Acute Disease; Adenine; Animals; Blood Pressure; Carbazoles; Coronary Circulation; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Female; Glyburide; Hypoxia; In Vitro Techniques; Indoles; Male; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Pyrroles; Rabbits; Signal Transduction; Thionucleotides; Vasodilation	2007
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia. Blood, 2007, Sep-15, Volume: 110, Issue:6 Topics: Acute Disease; Animals; Blotting, Western; Bone Marrow Cells; Cell Proliferation; Cyclin D2; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; fms-Like Tyrosine Kinase 3; G1 Phase; Humans; Immunoprecipitation; Indoles; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid; Mice; Mice, SCID; Morpholines; Mutation; Phosphorylation; Piperazines; Pyridines; Pyrroles; Retinoblastoma Protein; Signal Transduction; Tumor Cells, Cultured	2007
Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure. European journal of heart failure, 2007, Volume: 9, Issue:10 Topics: Acute Disease; Amides; Atorvastatin; Cardiac Pacing, Artificial; Clinical Trials as Topic; Fumarates; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pulmonary Edema; Pyrroles; Renin; Respiration, Artificial	2007
Leukocyte, plasma, and organ-associated cytokine profiles in an animal model of acute inflammation. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2008, Volume: 116, Issue:5 Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Cytokines; Disease Models, Animal; Down-Regulation; Endotoxemia; Female; Heart; Heptanoic Acids; Inflammation Mediators; Kidney; Leukocytes; Lipopolysaccharides; Myocardium; Organ Specificity; Pyrroles; Random Allocation; Swine; Up-Regulation	2008
Acute severe hypothyroidism induced by sunitinib. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2008, Volume: 89, Issue:1 Topics: Acute Disease; Aged; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Hypothyroidism; Indoles; Pyrroles; Sunitinib	2008
Severe coronary spasm during zomepirac-induced allergic reaction. Southern medical journal, 1984, Volume: 77, Issue:7 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Coronary Vasospasm; Drug Hypersensitivity; Female; Humans; Middle Aged; Pyrroles; Tolmetin	1984
Simple screening test for qualitative detection of increased delta-aminolevulinic acid in urine. Clinical chemistry, 1984, Volume: 30, Issue:8 Topics: Acute Disease; Aminolevulinic Acid; Benzaldehydes; Colorimetry; Humans; Levulinic Acids; Porphobilinogen Synthase; Porphyrias; Pyrroles	1984
Monopyrroles in porphyria, psychosis and lead exposure. The International journal of biochemistry, 1980, Volume: 12, Issue:5-6 Topics: 5-Aminolevulinate Synthetase; Acute Disease; Aminolevulinic Acid; Animals; Heme Oxygenase (Decyclizing); Humans; Lead Poisoning; Leukocytes; Liver; Male; Porphyrias; Porphyrins; Psychotic Disorders; Pyrroles; Rats	1980
[Treatment of acute gout attacks with tolmetin (author's transl)]. Wiener medizinische Wochenschrift (1946), 1982, Jan-31, Volume: 132, Issue:2 Topics: Acute Disease; Adult; Aged; Analgesia; Gout; Humans; Male; Middle Aged; Pyrroles; Tolmetin; Uric Acid	1982
Acute thrombocytopenic purpura traced to tolmetin-related antibody. Virginia medical, 1982, Volume: 109, Issue:3 Topics: Acute Disease; Antibody Formation; Blood Platelets; Female; Humans; Middle Aged; Platelet Count; Purpura, Thrombocytopenic; Pyrroles; Tolmetin	1982
Tolmetin. Association with reversible renal failure and acute interstitial nephritis. JAMA, 1981, Jul-17, Volume: 246, Issue:3 Topics: Acute Disease; Acute Kidney Injury; Aged; Biopsy; Female; Humans; Kidney; Nephritis, Interstitial; Osteoarthritis; Pyrroles; Tolmetin	1981
Urine concentration of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one ('mauve factor') is not causally related to schizophrenia or to acute intermittent porphyria. Clinical science (London, England : 1979), 1980, Volume: 58, Issue:6 Topics: Acute Disease; Adult; Chromatography, Gas; Female; Humans; Porphyrias; Pyrroles; Schizophrenia	1980
New drugs for renal colic therapy--in-vitro and animal experiments. Investigative urology (Berlin, Germany), 1994, Volume: 5 Topics: Acute Disease; Animals; Benzopyrans; Colic; Cromakalim; Dogs; Drug Evaluation, Preclinical; Female; Isometric Contraction; Kidney Calculi; Kidney Pelvis; Manometry; Muscle, Smooth; Potassium Channels; Pyrroles; Ureter; Ureteral Obstruction; Urodynamics	1994
Glibenclamide does not reverse attenuated vasoreactivity to acute or chronic hypoxia. Journal of applied physiology (Bethesda, Md. : 1985), 1995, Volume: 79, Issue:4 Topics: Acute Disease; Adenosine Triphosphate; Animals; Benzopyrans; Blood Gas Analysis; Blood Pressure; Chronic Disease; Cromakalim; Glyburide; Heart Rate; Hemodynamics; Hypoglycemic Agents; Hypoxia; Male; Phenylephrine; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstrictor Agents	1995
Acute hypoxic vasoconstriction in isolated rat small and large pulmonary arteries. Physiological research, 1995, Volume: 44, Issue:1 Topics: Acute Disease; Amlodipine; Animals; Benzopyrans; Calcium Channel Blockers; Cromakalim; Endothelium, Vascular; Hypoxia; In Vitro Techniques; Male; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; Vasoconstriction; Vasodilator Agents	1995
[Acute pancreatitis associated with atorvastatine therapy]. Gastroenterologie clinique et biologique, 2000, Volume: 24, Issue:4 Topics: Acute Disease; Anticholesteremic Agents; Atorvastatin; Heptanoic Acids; Humans; Male; Middle Aged; Pancreatitis; Pyrroles	2000
Acute rhabdomyolysis after atorvastatin and fusidic acid therapy. The American journal of medicine, 2000, Volume: 109, Issue:1 Topics: Acute Disease; Aged; Angioplasty, Balloon; Anti-Bacterial Agents; Arterial Occlusive Diseases; Atorvastatin; Drug Therapy, Combination; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Surgical Wound Infection; Tibial Arteries	2000
Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. Blood, 2001, Jul-01, Volume: 98, Issue:1 Topics: Acute Disease; Angiogenesis Inhibitors; Antineoplastic Agents; Bone Marrow Cells; Endothelium, Vascular; Female; Humans; Immunohistochemistry; Indoles; Leukemia, Myeloid; Middle Aged; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Remission Induction	2001
Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:7 Topics: Acute Disease; Apoptosis; Atorvastatin; Cell Division; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Leukemia, Myeloid; Lovastatin; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Pyrroles; Sensitivity and Specificity; Tumor Cells, Cultured	2001
Atorvastatin for acute coronary syndromes. JAMA, 2001, Aug-01, Volume: 286, Issue:5 Topics: Acute Disease; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles	2001
Atorvastatin for acute coronary syndromes. JAMA, 2001, Aug-01, Volume: 286, Issue:5 Topics: Acute Disease; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles	2001
Acute cholestatic hepatitis after reinitiating treatment with atorvastatin. Journal of hepatology, 2002, Volume: 37, Issue:1 Topics: Acute Disease; Aged; Atorvastatin; Cholestasis; Hepatitis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles	2002
Quantitation of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one in the urine of patients with acute intermittent porphyria. European journal of clinical investigation, 1979, Volume: 9, Issue:1 Topics: Acute Disease; Adult; Aminolevulinic Acid; Chromatography, Gas; Female; Heme; Humans; Porphobilinogen; Porphyrias; Pyrroles	1979
Pharmacological and biochemical properties of kryptopyrrole and its oxidation products possibly related to acute intermittent porphyria. Annals of clinical research, 1976, Volume: 8 Suppl 17 Topics: Acute Disease; Animals; Behavior, Animal; Body Temperature; Humans; Male; Mice; Porphyrias; Pyrroles; Reaction Time	1976
Tolmetin-induced acute renal failure. A case report. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1986, Aug-16, Volume: 70, Issue:4 Topics: Acute Disease; Acute Kidney Injury; Humans; Male; Middle Aged; Nephritis, Interstitial; Peritoneal Dialysis; Pyrroles; Tolmetin	1986
Kryptopyrrole-like substance in acute intermittent porphyria. Lancet (London, England), 1972, Dec-02, Volume: 2, Issue:7788 Topics: Acute Disease; Humans; Porphyrias; Pyrroles	1972
Isolated adrenocorticotrophic hormone deficiency in acute intermittent porphyria. Annals of internal medicine, 1969, Volume: 70, Issue:2 Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acute Disease; Adrenocorticotropic Hormone; Adult; Blood Glucose; Diet; Diet Therapy; Dietary Carbohydrates; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Lactates; Male; Metyrapone; Pituitary-Adrenal Function Tests; Porphyrias; Porphyrins; Pyrroles; Pyruvates	1969
Urinary dipyrrylmethenes in patients with porphyria. A preliminary study of the brown pigments in the urine of a case of acute intermittent porphyria. Enzyme, 1974, Volume: 17, Issue:1 Topics: Acute Disease; Adult; Bilirubin; Chromatography, Thin Layer; Humans; Male; Pigments, Biological; Porphobilinogen; Porphyrias; Porphyrins; Pyrroles; Urobilin	1974
Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism. The New England journal of medicine, 1972, Jun-15, Volume: 286, Issue:24 Topics: 5-Aminolevulinate Synthetase; Acute Disease; Adolescent; Adult; Erythrocytes; Feces; Female; Humans; Levulinic Acids; Lyases; Male; Pedigree; Porphobilinogen; Porphyrias; Porphyrins; Propionates; Pyrroles	1972
The measurement of the synthetic rate of bilirubin from hepatic hemes in patients with acute intermittent porphyria. The Journal of clinical investigation, 1971, Volume: 50, Issue:11 Topics: Acute Disease; Adult; Amino Acids; Bilirubin; Carbon Isotopes; Female; Heme; Humans; Levulinic Acids; Liver; Male; Porphyrias; Propionates; Pyrroles; Spectrophotometry; Tritium	1971
Acute intermittent porphyria. A clinical, biochemical and family study. Journal of medicine, 1971, Volume: 2, Issue:3 Topics: Acetone; Acute Disease; Adenosine Monophosphate; Child, Preschool; Glycine; Humans; Injections, Intramuscular; Levulinic Acids; Liver; Male; Pedigree; Porphyrias; Porphyrins; Propionates; Pyrroles	1971
Medical College of Georgia Medical Grand Rounds. Acute intermittent porphyria. Journal of the Medical Association of Georgia, 1970, Volume: 59, Issue:9 Topics: Acute Disease; Adult; Diagnosis, Differential; Female; Humans; Porphyrias; Porphyrins; Propionates; Pyrroles	1970
Diagnosis of a case of acute intermittent porphyria with the aid of thin-layer chromatography-thin-layer electrophoresis of urine. Clinical chemistry, 1971, Volume: 17, Issue:1 Topics: Acute Disease; Amino Acids; Chromatography, Thin Layer; Color; Electrophoresis; Humans; Indicators and Reagents; Levulinic Acids; Porphyrias; Propionates; Pyrroles	1971
Biochemical basis and regulatory mechanisms of porphyrin synthesis. Proceedings of the Royal Society of Medicine, 1968, Volume: 61, Issue:2 Topics: Acute Disease; Amino Acids; Animals; Enzyme Repression; Erythrocytes; Erythrocytes, Abnormal; Erythropoiesis; Guinea Pigs; Humans; Hydro-Lyases; Levulinic Acids; Porphyrias; Porphyrins; Pyrroles; Rats	1968
Diagnosis and treatment of the porphyrias. Proceedings of the Royal Society of Medicine, 1968, Volume: 61, Issue:2 Topics: Acute Disease; Amino Acids; Erythropoiesis; Feces; Female; Humans; Levulinic Acids; Liver Diseases; Male; Photosensitivity Disorders; Porphyrias; Porphyrins; Pyrroles; Skin Diseases; Skin Manifestations	1968